Jose G Trevino M D P A is categorized under Internal Medicine Doctors in Dallas, TX and active since 2005.
Jose G Trevino M D P A was established in 2005, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Jose G Trevino at the company’s single location by writing to 3141 Irving Boulevard # 220, Dallas, Texas TX 75247 or by phoning (214) 630-1144. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Jose G Trevino M D P A |
Contact Person: | Jose G Trevino |
Address: | 3141 Irving Boulevard # 220, Dallas, Texas 75247 |
Phone Number: | (214) 630-1144 |
Website Address: | medalertonline.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2005 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Jose G Trevino M D P A was started in 2005 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jose G Trevino for inquiries that concern Jose G Trevino M D P A by calling the company number (214) 630-1144, as your correspondence is most welcome. Additionally, the physical location of the single location of Jose G Trevino M D P A can be found at the coordinates 32.808126,-96.864996 as well as the street address 3141 Irving Boulevard # 220 in Dallas, Texas 75247.
For its online presence, you may visit Jose G Trevino M D P A’s website at medalertonline.com and engage with its social media outlets through on Twitter and on Facebook.